Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2020		72,459,255
Beginning balance at Dec. 31, 2020	$ 905,073	$ 72	$ 850,430	$ 54,571	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	25,671			25,671
Share-based employee compensation	53,637		53,637
Issuance of common stock - vesting of restricted stock units (in shares)		106,110
Issuance of common stock – vesting of restricted stock units	0	$ 1	(1)
Common stock issued in connection with business (in shares)		994,028
Common stock issued in connection with business combination	24,910	$ 1	24,909
Exercise of stock options (in shares)		6,242
Exercise of stock options	95		95
Cancellation of unvested restricted stock awards (in shares)		(2,918)
Change in fair value of convertible notes receivable, net	0
Ending balance (in shares) at Dec. 31, 2021		73,562,717
Ending balance at Dec. 31, 2021	1,009,386	$ 74	929,070	80,242	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	103,261			103,261
Share-based employee compensation	13,876		13,876
Issuance of common stock - vesting of restricted stock units (in shares)		284,168
Issuance of common stock – vesting of restricted stock units	0
Exercise of stock options (in shares)		711
Exercise of stock options	0
Change in fair value of convertible notes receivable, net	(157)				(157)
Ending balance (in shares) at Dec. 31, 2022		73,847,596
Ending balance at Dec. 31, 2022	1,126,366	$ 74	942,946	183,503	(157)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	123,119			123,119
Share-based employee compensation	16,388		16,388
Issuance of common stock - vesting of restricted stock units (in shares)		383,592
Issuance of common stock – vesting of restricted stock units	0
Exercise of stock options (in shares)		116,746
Exercise of stock options	1,366		1,366
Change in fair value of convertible notes receivable, net	143				143
Exercise of stock appreciation rights (in shares)		24,955
Ending balance (in shares) at Dec. 31, 2023		74,372,889
Ending balance at Dec. 31, 2023	$ 1,267,382	$ 74	$ 960,700	$ 306,622	$ (14)